As of 2026-03-16, the EV/EBITDA ratio of Silk Road Medical Inc (SILK) is -20.52. EV/EBITDA ratio is calculated by dividing the enterprise value by the TTM EBITDA. SILK's latest enterprise value is 1,170.43 mil USD. SILK's TTM EBITDA according to its financial statements is -57.03 mil USD. Dividing these 2 quantities gives us the above SILK EV/EBITDA ratio.
Note: valuation result may not be accurate due to the company's negative EBITDA.
| Range | Selected | |
| Trailing P/E multiples | 13.9x - 16.3x | 13.9x |
| Forward P/E multiples | 12.7x - 17.1x | 15.0x |
| Fair Price | (20.77) - (24.22) | (21.56) |
| Upside | -175.6% - -188.1% | -178.4% |
| Date | EV/EBITDA |